Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P21217: Variant p.Arg160Cys

3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3
Gene: FUT3
Feedback?
Variant information Variant position: help 160 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Cysteine (C) at position 160 (R160C, p.Arg160Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help Genetic variations in FUT3 define the Lewis blood group system (LE) [MIM:618983]. FUT3 catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. Variations in this gene are responsible for the majority of Lewis antigen-negative phenotypes (Le(-)). Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 160 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 361 The length of the canonical sequence.
Location on the sequence: help PPNCQHLEALDRYFNLTMSY R SDSDIFTPYGWLEPWSGQPA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         PPNCQHLEALDRYFNLTMSYRSDSDIFTPYGWLEPWSGQPA

Chimpanzee                    PPNCQHLEALDRYFNLTMSYRSDSDIFTPYGWLEPWSGQPA

Bovine                        PSNCLKLKDLDGYFNLTMSYRRDSDIFMPYGWLEPWPSQPV

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 361 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3
Topological domain 35 – 361 Lumenal
Glycosylation 154 – 154 N-linked (GlcNAc...) asparagine



Literature citations
Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS LE(-) ARG-20; ASN-162; SER-170; ARG-223 AND MET-270; VARIANTS SER-5; CYS-160; MET-325 AND GLN-327; VARIANTS TRP-68 AND THR-105;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.